Seroprevalence and Serointensity of Latent Toxoplasma gondii in a Sample of Elderly Adults with and Without Alzheimer Disease

Alzheimer Disease and Associated Disorders

Volumn 30, Issue 2, 2016, Pages 123-126

  Perry, Cynthia E ^a   Gale, Shawn D ^a   Erickson, Lance ^a   Wilson, Eric ^a   Nielsen, Brent ^a   Kauwe, John ^a   Hedges, Dawson W ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Alzheimer disease; neurodegeneration; Toxoplasma gondii; toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROPREVALENCE; SEX; SOCIAL STATUS; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; BLOOD; COMPLICATION; IMMUNOLOGY; SEROEPIDEMIOLOGY; TOXOPLASMA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84944339887     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000108     Document Type: Article

References (16)

1. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010;362:329-344.
2. Bekris LM, Yu CE, Bird TD, et al. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23:213-227.
3. deBruijn RF, Ikram MA. Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med. 2014;12:130.
4. Katan M, Moon YP, Paik MC, et al. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology. 2013;80:1209-1215.
5. Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms. Folia Parasitol (Praha). 2010;57:105-113.
6. Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iran J Parasitol. 2012;7:1-17.
7. Kannan G, Pletnikov MV. Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective. Schizophr Bull. 2012;38:1155-1161.
8. Flegr J, Prandota J, Sovickova M, et al. Toxoplasmosis - a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014;9:e90203.
9. Jones JL, Kruszon-Moran D, Wilson M, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 2001;154:357-365.
10. Kusbeci OY, Miman O, Yaman M, et al. Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord. 2011;25:1-3.
11. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
12. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-269.
13. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
14. Hollingshead AB, Redlich FC. Social Class and Mental Illness. New York, NY: John Wiley & Sons; 1958.
15. Gale SD, Brown BL, Erickson LD, et al. Association between latent toxoplasmosis and cognition in adults: a cross-sectional study. Parasitology. 2015;142:557-565.
16. Xiao J, Yolken RH. Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases. Actaphysiologica. 2015;213:828-845.